Brief: Fusen Pharmaceutical Co Says Co Has Not Carried Out Research Activities On Effectiveness Of Drug For Inhibiting Novel Coronavirus
03/02/2020 01:19
Feb 3 (Reuters) - Fusen Pharmaceutical Company Ltd
1652.HK :
* HAS NOT CARRIED OUT RESEARCH ACTIVITIES ON EFFECTIVENESS
OF
SHUANGHUANGLIAN ORAL SOLUTIONS FOR INHIBITING NOVEL CORONAVIRUS
* NOTES RECENT MEDIA REPORTS REGARDING EFFECTIVENESS OF
SHUANGHUANGLIAN ORAL SOLUTIONS IN INHIBITING CORONAVIRUS
* WILL ADJUST PRODUCTION CAPACITY OF SHUANGHUANGLIAN ORAL
SOLUTIONS TO MEET MARKET DEMAND
Source text for Eikon: ID:nHKS8RGYm1
Further company coverage: 1652.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA